Children with moderately elevated blood lead levels: A role for other diagnostic tests?

Environmental Health Perspectives

Volumn 105, Issue 10, 1997, Pages 1084-1088

  Markowitz, Morri E ^a,b   Clemente, Isabella ^b   Rosen, John F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Blood lead levels; Chelation; Erythrocyte protoporphyrin; Iron deficiency; Lead diagnosis; Lead mobilization test; Lead poisoning; Urine lead

Indexed keywords

CHELATING AGENT; EDETATE CALCIUM DISODIUM; ERYTHROCYTE PROTOPORPHYRIN; HEMOGLOBIN; LEAD;

ARTICLE; BLOOD CELL COUNT; CHELATION THERAPY; DIURESIS; ERYTHROCYTE; HUMAN; IRON DEFICIENCY; LEAD BLOOD LEVEL; LEAD POISONING; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0031410761     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.971051084     Document Type: Article

References (29)

1. CDC. Preventing Lead Poisoning in Children: A Statement by the Centers for Disease Control. Atlanta, GA:Centers for Disease Control, 1991.
2. Committee on Environmental Health. Lead poisoning from screening to prevention. Pediatrics 92:176-183 (1993).
3. CDC. Preventing Lead Poisoning in Children: A Statement by the Centers for Disease Control. Atlanta, GA:Centers for Disease Control, 1985.
4. Piomelli S. Free erythrocyte porphyrins in the detection of undue absorption of lead and iron deficiency. Clin Chem 23:249-259 (1977).
5. McElvaine MD, Orbach HG, Binder S, Blanksma LA, Maes EF, Krieg RM. Evaluation of the erythrocyte protoporphyrin test as a screen for elevated blood lead levels. J Pediatr 119:548-550 (1991).
6. Mahaffey KR, Annest JL. Association of erythrocyte protoporphyrin with blood lead level and iron status in the second National Health Nutrition Examination Survey, 1976-1980. Environ Res 41:327-338 (1986).
7. Treatment guidelines for lead exposure in children. American Academy of Pediatrics Committee on Drugs. Pediatrics 96:155-160 (1995).
8. Rosen JF, Crocetti AM, Balbi K. Bone lead content assessed by L-line X-ray fluorescence in lead-exposed and non-lead exposed suburban populations in the United States. Proc Natl Acad Sci USA 90:2789-2792 (1993).
9. Whittaker JA, Austin W, Nelson JD. Edathamil calcium disodium diagnostic test for lead poisoning. Pediatrics 29:384-388 (1962).
10. Markowitz ME, Rosen JF. Need for the lead mobilization test in children with lead poisoning. J Pediatr 119:305-310 (1991).
11. 2EDTA provocative test. J Pediatr 104:337-341 (1984).
12. Weinberger HL, Post EM, Schneider T, Helu B, Friedman J. An analysis of 248 initial mobilization tests performed on an ambulatory basis. Am J Dis Child 141:1266-1270 (1987).
13. Cory-Slechta DA, Weiss B, Cox C. Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy. J Pharmacol Exp Ther 243:804-813 (1987).
14. Piomelli S, Rosen JF, Chisolm JJ Jr, Graef JW. Management of childhood lead poisoning. J Pediarr 105:523-532 (1984).
15. Jackson RT. Separate hemoglobin standards for blacks and whites: a critical review of the case for separate and unequal hemoglobin standards. Med Hypotheses 32:181-189 (1990).
16. Mahaffey KR, Annest JL, Roberts J, Murphy RS. National estimates of blood lead levels: United States, 1976-1980. Association with selected demographic and socioeconomic factors. N Engl J Med 307:573-579 (1982).
17. Glotzer DE, Bauchner H. Management of childhood lead poisoning: a survey. Pediatrics 89:614-618 (1992).
18. Graziano JH, Lolacono NJ, Meyer P. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations. J Pediatr 113:751-757 (1988).
19. Graziano JH, Lolacono NJ, Moulton T, Mitchell ME, Slavkovich V, Zarate C. Controlled studies of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication. J Pediatr 120:133-139 (1992).
20. 204Pb. Environ Res 67:39-53 (1994).
21. Oski FA. Iron deficiency in infancy and childhood. N Engl J Med 329:190-193 (1993).
22. Markowitz ME, Rosen JF, Bijur PE. Effects of iron deficiency on lead excretion in children with moderate lead intoxication. J Pediartr 116:360-364 (1990).
23. Smith CM, Wang X, Hu H, Kelsey KT. A polymorphism in the δ-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect 103:248-253 (1995).
24. Markowitz ME, Bijur PE, Ruff H, Rosen JF. Effects of calcium disodium versenate chelation in moderate childhood lead poisoning. Pediatrics 92:265-271 (1993).
25. 2EDTA test in lead-toxic children: public health implications. Proc Natl Acad Sci 86:685-689 (1989).
26. 2EDTA-treated lead-toxic children. Environ Health Perspect 93:271-277 (1991).
27. Ruff HA, Bijur PE, Markowitz ME, Ma YC, Rosen JF. Declining blood lead levels and cognitive changes in moderately lead-poisoned children. JAMA 269:1641-6 (1993).
28. Hammond PB. The effects of chelating agents on the tissue distribution and excretion of lead. Toxicol Appl Pharmacol 18:206-310 (1973).
29. Flood PR, Schmidt PF, Wesenberg GR, Gadeholt H. The distribution of lead in human hemopoietic tissue and spongy bone after lead poisoning and Ca-EDTA chelation therapy. Arch Toxicol 62:295-300 (1988).